Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Fenofibrate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fenofibrate micronised 160mg tablets
0212000P0AAAEAE
|
Fenofibrate | Fenofibrate | Cardiovascular System | 63,396 |
|
Fenofibrate micronised 200mg capsules
0212000P0AAABAB
|
Fenofibrate | Fenofibrate | Cardiovascular System | 53,355 |
|
Fenofibrate micronised 267mg capsules
0212000P0AAADAD
|
Fenofibrate | Fenofibrate | Cardiovascular System | 35,136 |
|
Fenofibrate micronised 67mg capsules
0212000P0AAACAC
|
Fenofibrate | Fenofibrate | Cardiovascular System | 14,971 |
|
Fenofibrate 200mg capsules
0212000P0AAAFAF
|
Fenofibrate | Fenofibrate | Cardiovascular System | 10 |
|
Fenofibrate 160mg/5ml oral solution
0212000P0AAAGAG
|
Fenofibrate | Fenofibrate | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.